Hyllengren Eric J 4
4 · Atara Biotherapeutics, Inc. · Filed May 20, 2024
Insider Transaction Report
Form 4
Hyllengren Eric J
EVP, CFO and COO
Transactions
- Sale
Common Stock
2024-05-16$0.62/sh−28,648$17,676→ 645,671 total
Footnotes (2)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2024 and May 17, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.